Additionally, WHO recommends LF-LAM irrespective of symptoms for inpatients with AHD, and among symptomatic outpatients with a CD4 count of 100–200 cells/mm3. The gene discussed is CD4; the disease is mitochondrial DNA depletion syndrome 4a.